Yes. AFFY has only Omontys which is recalled. No other product whatsoever. IMHO management is stunned since it is faced with massive damage control, trying to find out what the true safety endpoints are for Omontys, trying to find out what caused Omontys to be deadly, no revenues coming in since product is DOA, lots of unexpected cash outlays for new research, FDA coordination, PR to fix a bad reputation, expensive lawywers, etc. etc. There is no easy fix for AFFY or Omontys here.
Management is sitting with FBI on - How come FDA Director issue recall out of 14 incidences/ 2 serious whereas LABEL clearly indicates Adverse reactions. EPOGEN has 5% cases of Adverse reactions without RECALL.